SCHEMBL18436848

SCHEMBL18436848

CC(C)(O)c1ccc(N2CCNCC2)nc1C(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 1/20 0.57
▸ CYP1A2 P05177 3/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ ADRB1 P08588 3/20 0.43
▸ HTR3E A5X5Y0 3/20 0.42
▸ HTR3B O95264 3/20 0.42
▸ HTR3A P46098 3/20 0.42
▸ HTR3D Q70Z44 3/20 0.42
▸ HTR3C Q8WXA8 3/20 0.42
▸ HTR2C P28335 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ HTR7 P34969 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ HTR6 P50406 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19012363 0.84 ADRB2 (0.39) ADRB2CYP1A2HTR3EHTR3BHTR3A
SCHEMBL19012355 0.84 HRH4 (0.46) ADRB2CYP1A2HTR3EHTR3BHTR3A
SCHEMBL29388809 0.74 ADRB2 (0.97) ADRB2CYP1A2CYP2C9ADRB1HTR3E
SCHEMBL906077 0.74 ADRB2 (0.97) ADRB2CYP1A2CYP2C9ADRB1HTR3E
SCHEMBL5585294 0.73 ADRB2 (0.62) ADRB2CYP1A2CYP2C9ADRB1HTR3E
SCHEMBL5585796 0.73 ADRB2 (0.58) ADRB2CYP1A2CYP2C9ADRB1HTR3E
Hydrochloric Acid SCHEMBL5585896 0.72 ADRB2 (1.00) ADRB2CYP1A2CYP2C9ADRB1HTR3E
SCHEMBL19001080 0.72 ADRB2 (0.40) ADRB2CYP1A2HTR3EHTR3BHTR3A
SCHEMBL4117671 0.71 ALDH1A1 (0.61) ADRB2ALDH1A1KDM4EIRAK4
SCHEMBL17128345 0.71 OGA (0.50) ADRB1ALDH1A1KDM4EHRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 — — EP disclosed
Send feedback